44 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
21 Nov 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
7:02pm
all foreign, federal, provincial, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
8-K
EX-10.1
pezma73co6pkt2x boyd
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.2
xdngzq3r nde7
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.1
x05drji
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
07aqt seqrh3vw8jjck1
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
lgtrbm7 4sk
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
apj0i 7w0am6
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
62unh31qf
7 Apr 22
Prospectus supplement
4:46pm
S-3
xnz4l14s
4 Feb 22
Shelf registration
4:36pm
DEF 14A
4tnkqo4qcfpqwyt0b51
28 Oct 21
Definitive proxy
3:07pm
DEFA14A
86r74um6159sh
28 Oct 21
Additional proxy soliciting materials
2:54pm
8-K
EX-2.1
l5mv9d
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
EX-2.1
yuxip7vud
24 Sep 21
Annual report
7:31am
10-K
6ryok8
24 Sep 21
Annual report
7:31am